Cargando…
Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers
A significant proportion of the personal and economic burden of schizophrenia can be attributed to the late diagnosis or misdiagnosis of the disorder. A novel, objective diagnostic approaches could facilitate the early detection and treatment of schizophrenia and improve patient outcomes. In the pre...
Autores principales: | Zaki, Jihan K., Lago, Santiago G., Rustogi, Nitin, Gangadin, Shiral S., Benacek, Jiri, van Rees, Geertje F., Haenisch, Frieder, Broek, Jantine A., Suarez-Pinilla, Paula, Ruland, Tillmann, Auyeung, Bonnie, Mikova, Olya, Kabacs, Nikolett, Arolt, Volker, Baron-Cohen, Simon, Crespo-Facorro, Benedicto, Drexhage, Hemmo A., de Witte, Lot D., Kahn, René S., Sommer, Iris E., Bahn, Sabine, Tomasik, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618570/ https://www.ncbi.nlm.nih.gov/pubmed/36310155 http://dx.doi.org/10.1038/s41398-022-02229-w |
Ejemplares similares
-
Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
por: Aichholzer, Mareike, et al.
Publicado: (2022) -
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial
por: Sommer, Iris E, et al.
Publicado: (2021) -
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo
por: Lago, Santiago G., et al.
Publicado: (2019) -
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
por: Batalla, Albert, et al.
Publicado: (2019) -
Using decision-analysis modelling to estimate the economic impact of the identification of unrecognised bipolar disorder in primary care: the untapped potential of screening
por: Benacek, Jiri, et al.
Publicado: (2022)